The week's thread — 20 September

Twenty-one rounds. Roughly €384 million raised across twelve countries — though strip out EUCLYD's €200 million-plus infrastructure megadeal from Eindhoven and the underlying figure across the other twenty rounds sits at approximately €184 million. Five briefs, Monday through Saturday. The week's shape: large bets on infrastructure and agents, with a predictably silent weekend.

The autonomy claim, now a mainstream underwriting premise

The distinctive word running across this week's application-layer rounds is delegation, not automation. At least six funded companies are building products that claim to complete professional workflows, not assist with a portion of them.

Magentic (London, €15M Series A) runs procurement agents inside manufacturers' enterprise systems: supplier selection, contract negotiation, order placement, invoice clearance — with human escalation only when a decision falls outside operating parameters. Revenue grew 40× from seed. Health Force (Barcelona, €4.2M Seed) closes hospital administrative workflows — prior authorisations, scheduling, claims — in three of four cases without human involvement, using standard staff credentials and no new system install. Jack & Jill (London, €34.7M Series A) runs two agents simultaneously: one facing candidates, one facing employers, connecting them only when both conclude the match is worth making. Delos (Paris, €10M Series A) places named virtual workers — with email addresses, phone numbers, and long-term memory — inside enterprise organisations. Logibot (Belgium, €1.4M) operates as a temp agency for humanoid robots in logistics warehouses. Zero (Helsinki, €9M Seed) builds a CRM that maintains itself: signals from email, calendar, and calls, no manual entry.

The qualification that applies across all six is the same: the delegation claim is unproven at the scale and accountability level implied. Magentic is fourteen months old; Health Force's product is running at three of four cases, not four of four. Whether enterprise buyers will grant consequential authority — not just access — to software this young is what these rounds collectively exist to find out. That six companies in the same week are betting it will happen is no longer a coincidence. It is a sector consensus forming.

Infrastructure at three altitudes

EUCLYD (Eindhoven, €200M+ Series A, co-led by Samsung and EQT's Scaleup Europe Fund) is the week's headline by distance. The company is designing custom AI silicon to reduce cost-per-token in transformer inference — the compute bottleneck that currently caps what autonomous agents can run economically at scale. Peter Wennink, former ASML CEO who presided over the most consequential semiconductor supply chain of the last decade, joins as board chairman. This is not an application investment; it is an argument that the hardware layer needs to be rebuilt, and that the economics of autonomous AI will look different once it is.

Two smaller infrastructure bets complete the stack. Tusk IC (Leuven, €15M Series A) makes the world's first standard-CMOS beamformer chips for Ka-band satellite antennas — closing the cost gap that keeps satellite connectivity in the enterprise tier rather than treating it as ambient infrastructure. Treble (Reykjavík, €15M Series A-2) builds physics-based acoustic simulation, generating the synthetic audio training data that autonomous systems operating in physical environments will need to hear reliably. EUCLYD addresses the inference layer; Tusk IC the connectivity layer; Treble the sensory layer.

Belgium's PMV backed both Tusk IC and Logibot in the same seven days — the chip substrate and the orchestration layer above it. One institutional fund, one week, two adjacent rungs of an emerging stack being built across Flanders.

Geography and the rest

The UK led by round count — five deals: Magentic, Jack & Jill, Resolutiion, MicroLub, Magnitude Biosciences — and roughly by capital excluding EUCLYD. France contributed two confirmed Series A deals — Arlequin AI (€28M, complex-data AI, co-led by Redalpine and OTB Ventures) and Delos — both above €10 million, with nothing from Paris below that threshold this week, a departure from the city's usual distribution. Germany's Munich cluster continued its pattern: FRYTE Mobility, Grubel, and Depotcharge in seven days, three different sectors, the same postcode. Belgium produced three rounds — IVEX, Tusk IC, Logibot — all deep-tech, all in Flanders.

Creem (Tallinn, €5M Seed), EnforceShield (Vilnius, €1.7M Seed), and Health Force (Barcelona, €4.2M Seed) represent the geographic range the ProYarn wire now covers as routine: the Baltic and Iberian rounds that a France-and-Germany-first framing used to miss.

Stage mix: eight confirmed Series A (plus one Series A-2), six Seed, three Pre-Seed, three with no stage stated by any source. HTGF backed two German rounds in one week: Depotcharge and syte. Northern Gritstone led MicroLub for the second consecutive time, converting its 2024 seed lead into a follow-on — the clearest vote of conviction for protein-based biolubricants this week.

Twenty-one rounds, twelve countries. The week's through-line is the autonomy claim asserting itself loudly enough, in enough sectors and enough funding rounds, that it is starting to look less like a shared pitch deck and more like a shared premise.